For three quarters in a row, there have been at least 20 publicly announced acquisitions of home health or hospice companies, a much higher quarterly volume than during most of 2017, according to new data from HealthCareMandA.com
(Irving Levin Associates). Private equity-backed home health companies were the most prolific buyers in the third quarter. During a recent BVR webinar
, healthcare valuation experts Darcy Devine
(Buckhead FMV) and Will Hamilton
(Veralon) explained that hospice firms (that also often include home health) enjoy operating margins of 8% to 9% compared to the smaller margins of most other healthcare entities, which makes them attractive M&A targets.
Please let us know
if you have any comments about this article or enhancements you would like to see.